Skip to main content

Madden Securities Corp

SEC CIK
0001803566
Latest filing
Jul 24, 2026

RETA holding history

Reata Pharmaceuticals Inc in every 13F filed by Madden Securities Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RETA overviewAll 13F holders of RETAFull Q2 2026 holdings

Shares (Q3 2023)
0
Sold out in Q3 2023
Value
$0
% of portfolio
0.0%
Quarters held
10
Since Q1 2021
Holdings of RETA by Madden Securities Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20230$00.0%−21,000−100.0%Sold outHolders
Q2 202321,000$2.14M1.1%−2,708−11.4%ReducedHolders
Q1 202323,708$2.16M1.1%00.0%UnchangedHolders
Q4 202223,708$900.7K0.5%00.0%UnchangedHolders
Q3 202223,708$596.0K0.4%−60−0.3%ReducedHolders
Q2 202223,768$722.0K0.4%00.0%UnchangedHolders
Q1 202223,768$779.0K0.4%−15,544−39.5%ReducedHolders
Q4 202139,312$1.04M0.5%+6,185+18.7%AddedHolders
Q3 202133,127$3.33M1.8%−1,675−4.8%ReducedHolders
Q2 202134,802$4.93M2.6%+150.0%AddedHolders
Q1 202134,787$3.47M2.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.